Imvotamab

imvotamab · IGM Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Imvotamab, covering 2024-07-24 to 2025-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis [Phase 1]